Pharmaceutical

Cipla to bolster OTC portfolio with acquisition of Actor Pharma

Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharma to bolster over-the-counter (OTC) product portfolio.

Sep 5, 2023 - 20:00
Cipla to bolster OTC portfolio with acquisition of Actor Pharma
Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharma to bolster over-the-counter (OTC) product portfolio.
Read the original article

Tags:

Previous Article

invIOs’s cell therapy secures Austrian Government grant for Phase Ib trial

Next Article

UK MHRA approves AbbVie’s migraine prevention drug Aquipta

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

Taiho exercises option for Arcus Biosciences’ quemliclu...

Jul 10, 2024

Bayer teams up with lncRNA-focused NextRNA in $547m deal

Bayer teams up with lncRNA-focused NextRNA in $547m deal

Aug 29, 2024

Advocates expect Supreme Court Idaho abortion decision to fuel efforts to further restrict access

Advocates expect Supreme Court Idaho abortion decision ...

Jan 10, 2024